ROR = 6.71, 95% CI 6.187.3) Diabetic ketoacidosis (n = 383
Fadini GP, Frison V, Simioni N, et al
If you take levothyroxine, your dose may need adjustment as you lose weight
Within 48 hours, TGA officers descended on his house searching for evidence
5 In addition to approved indications, GLP-1 agonists may have a role in the management of cutaneous disease, as demonstrated through off-label treatment in the literature (Table 1)
GLP-1 receptor agonists are used in accordance with NICE guidance for managing type 2 diabetes (NG28) and, in defined circumstances, for weight management (TA875)